Abstracts

High peripheral monocyte count is associated with increased risk of venous thromboembolism in patients with advanced pancreatic cancer

Background Venous thromboembolism (VTE) represents a major cause of morbidity and mortality in patients (pts) with pancreatic ductal adenocarcinoma (PDAC). Previous stud...

06/27/2022

Outcome of local radiation therapy in oligo-recurrent biliary tract cancers

Background The role and impact of local treatment in the form of radiotherapy in oligo-recurrent biliary tract cancer is not very well defined. The aim of our study was ...

06/27/2022

Expression of HSP60 in colorectal cancer and implication in chemotherapeutic responses

Background Heat shock protein 60 (HSP60), also known as chaperonin and HSPD1, belongs to the heat shock protein family. The HSP60 protein is an intramitochondrial chaper...

06/27/2022

Efficacy of FLOT regimen in the Polish population – real-world data from a prospective biomarker study

Background Gastric cancer is associated with poor prognosis. Currently in Europe the preferred management of locally advanced gastric cancer (GC) and gastroesophageal ju...

06/27/2022

The controversial association of CHEK2 pathogenic variants and colorectal cancer susceptibility

Background Colorectal cancer (CRC) is the third most common cancer worldwide, with an estimated worldwide incidence of approximately 1 100 000 cases and 550 000 CCR asso...

06/27/2022

In vitro drug screening of patient-derived 3D tumoroids replicates resistance to FOLFOX, FOLFIRI, and FOLFOXIRI in clinically resistant patients with metastatic colorectal cancer

Background International guidelines present three different chemotherapy regimens for first- and subsequent-line treatment of unresectable metastatic colorectal cancer (...

06/27/2022

Molecular signature and MMR status of early- and late-onset colorectal cancer among Arabs

Background Early-onset colorectal cancer (EO-CRC) is increasing in alarming pace globally. Ethnical/ racial disparities in the EOCRC clinicopathological and molecular si...

A. Al Zaabi ;

H. Al Adawi ;

M. Al Shaibi ;

A. Al Shihi ;

F. Al Farsi ;

O. Al Alyani ;

A. Al Mirza ;

M. Al Asmi ;

T. Al Barhi ;

S. Elmoety ;

06/27/2022

Percentage of residual fibrosis versus Rubbia-Brandt classification as predictors of overall survival in metastatic colorectal cancer. Which is better?

Background Pathologic response to preoperative chemotherapy for colorectal liver metastases (CRLM) has been associated with survival after hepatectomy in some publicatio...

06/27/2022

Identification of serpin peptidase inhibitor clade A member 1 as a novel serum biomarker for gastric cancer and promotion of liver metastasis

Background Approximately 9. 9%～18. 7% of gastric cancer (GC) patients experience liver metastasis (LM) during the course of the disease and is highly associated with poo...

06/27/2022

Pattern of failure after radiotherapy for squamous cell carcinoma of the anus

Background Squamous cell carcinoma of the anus (SCCA) is primarily treated with radiotherapy (RT). Treatment failure is predominantly locoregional within the pelvic area...

06/27/2022